BlueRock Therapeutics
Bryan Gellner, PhD, P.Eng., is a highly skilled biomedical engineer with extensive experience in the design, development, and manufacture of medical devices. Currently serving as a Senior Biomedical Engineer at BlueRock Therapeutics since November 2022, Gellner previously held significant roles at Qvella Corporation, where key contributions included leading projects for a rapid sepsis detection system, and at Baylis Medical, focusing on the development of innovative catheter technologies. Gellner completed a PhD in Mechanical Engineering at the University of Toronto, where research emphasized enhancing organ evaluation protocols for heart transplants, and has a strong foundation in engineering education with a Master's and Bachelor's degree from the same institution. Notable earlier roles include positions in quality assurance and project engineering, showcasing a breadth of skills across various engineering fields.
BlueRock Therapeutics
2 followers
BlueRock Therapeutics: Repairing the body when it cannot repair itself